Clinical Trial Update: Safety & Immunogenicity of 426c.Mod.Core-C4b Vaccine With 3M-052-AF+Alum in Infants Perinatally Exposed to HIV But Uninfected [Phase 1]

View source ↗

Summary

This update outlines a Phase 1 study evaluating the safety and immunogenicity of the 426c.Mod.Core-C4b vaccine with 3M-052-AF+Alum in infants perinatally expose…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• 426c.Mod.Core-C4b vaccine with 3M-052-AF+Alum

Snippet

Sponsor: HIV Vaccine Trials Network | Conditions: HIV Infections | Phase 1 | Status: NOT_YET_RECRUITING